James Vane
Stock Analyst at Jefferies
(0.78)
# 3,901
Out of 4,476 analysts
504
Total ratings
49.5%
Success rate
-1.4%
Average return
Main Sectors:
Stocks Rated by James Vane
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: MRK Merck KGaA | Maintained: Hold | €129.00 | $145.65 | -11.43% | 3 | Jun 25, 2026 | |
| RGEDF Gedeon Richter PLC | Maintained: Buy | $45 → $48 | $39.76 | +20.15% | 7 | Jun 12, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Hold | CHF 110.00 | $127.92 | -14.01% | 4 | Jun 11, 2026 | |
| LON: OXB Oxford Biomedica plc | Reiterated: Buy | 827p | $619.00 | +33.60% | 4 | Jun 2, 2026 | |
| BME: ROVI Laboratorios Farmaceuticos Rovi, S.A. | Maintained: Hold | €83.50 → €64.20 | $56.90 | +12.83% | 9 | May 13, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | CHF 769.00 → CHF 762.00 | $574.20 | +32.71% | 12 | May 13, 2026 | |
| SWX: SFZN Siegfried Holding AG | Maintained: Hold | CHF 94.50 → CHF 88.00 | $71.80 | +22.56% | 3 | May 13, 2026 | |
| ETR: FRE Fresenius SE & Co. KGaA | Maintained: Buy | €57.00 → €55.00 | $42.43 | +29.63% | 80 | May 6, 2026 | |
| LON: HIK Hikma Pharmaceuticals PLC | Reiterated: Buy | 2,360p → 1,870p | $1,548.00 | +20.80% | 27 | May 5, 2026 | |
| ETR: FME Fresenius Medical Care AG | Maintained: Sell | €32.00 → €31.00 | $41.10 | -24.57% | 90 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 75.00 → CHF 84.00 | $72.34 | +16.12% | 5 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €307.00 | $226.60 | +35.48% | 34 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | zł 204.00 → zł 188.00 | $181.50 | +3.58% | 3 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €210.00 → €246.00 | $187.40 | +31.27% | 2 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €229.00 → €262.00 | $180.20 | +45.39% | 13 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €15.50 | $17.32 | -10.51% | 8 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €34.10 | $28.14 | +21.18% | 40 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $24.69 | - | 24 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 1,250p → 1,420p | $1,244.00 | +14.15% | 15 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €333.00 → €368.00 | $332.00 | +10.84% | 12 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | CHF 49.30 | $77.55 | -36.43% | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 260p → 298p | $219.00 | +36.07% | 17 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €49.00 → €61.50 | $51.35 | +19.77% | 3 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $13 | $39.80 | n/a | 30 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $17 → $18 | $23.53 | n/a | 8 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9.3 → $11 | $12.10 | n/a | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €4.49 | $4.22 | n/a | 7 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €49.00 | $34.97 | n/a | 23 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 147.00 → CHF 148.00 | $107.65 | n/a | 4 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | 300p | $223.20 | n/a | 1 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 630.00 → kr 1,150 | $395.74 | n/a | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €135.00 → €43.00 | $14.80 | n/a | 2 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €28.70 | $71.55 | n/a | 1 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $17.64 | n/a | 2 | Jan 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.41 | n/a | 1 | Dec 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 93.00 | $237.50 | n/a | 1 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $31 | $14.38 | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $41.21 | n/a | 1 | Aug 21, 2017 |
Merck KGaA
Jun 25, 2026
Maintained: Hold
Price Target: €129.00
Current: $145.65
Upside: -11.43%
Gedeon Richter PLC
Jun 12, 2026
Maintained: Buy
Price Target: $45 → $48
Current: $39.76
Upside: +20.15%
Novartis AG
Jun 11, 2026
Maintained: Hold
Price Target: CHF 110.00
Current: $127.92
Upside: -14.01%
Oxford Biomedica plc
Jun 2, 2026
Reiterated: Buy
Price Target: 827p
Current: $619.00
Upside: +33.60%
Laboratorios Farmaceuticos Rovi, S.A.
May 13, 2026
Maintained: Hold
Price Target: €83.50 → €64.20
Current: $56.90
Upside: +12.83%
Lonza Group AG
May 13, 2026
Maintained: Buy
Price Target: CHF 769.00 → CHF 762.00
Current: $574.20
Upside: +32.71%
Siegfried Holding AG
May 13, 2026
Maintained: Hold
Price Target: CHF 94.50 → CHF 88.00
Current: $71.80
Upside: +22.56%
Fresenius SE & Co. KGaA
May 6, 2026
Maintained: Buy
Price Target: €57.00 → €55.00
Current: $42.43
Upside: +29.63%
Hikma Pharmaceuticals PLC
May 5, 2026
Reiterated: Buy
Price Target: 2,360p → 1,870p
Current: $1,548.00
Upside: +20.80%
Fresenius Medical Care AG
May 5, 2026
Maintained: Sell
Price Target: €32.00 → €31.00
Current: $41.10
Upside: -24.57%
May 5, 2026
Maintained: Buy
Price Target: CHF 75.00 → CHF 84.00
Current: $72.34
Upside: +16.12%
Apr 23, 2026
Maintained: Buy
Price Target: €307.00
Current: $226.60
Upside: +35.48%
Apr 21, 2026
Maintained: Hold
Price Target: zł 204.00 → zł 188.00
Current: $181.50
Upside: +3.58%
Mar 18, 2026
Maintained: Buy
Price Target: €210.00 → €246.00
Current: $187.40
Upside: +31.27%
Mar 17, 2026
Maintained: Buy
Price Target: €229.00 → €262.00
Current: $180.20
Upside: +45.39%
Feb 11, 2026
Maintained: Hold
Price Target: €15.50
Current: $17.32
Upside: -10.51%
Feb 2, 2026
Maintained: Buy
Price Target: €34.10
Current: $28.14
Upside: +21.18%
Jan 16, 2026
Maintained: Hold
Price Target: n/a
Current: $24.69
Upside: -
Oct 29, 2025
Maintained: Hold
Price Target: 1,250p → 1,420p
Current: $1,244.00
Upside: +14.15%
Oct 22, 2025
Maintained: Hold
Price Target: €333.00 → €368.00
Current: $332.00
Upside: +10.84%
Sep 25, 2025
Initiated Coverage: Sell
Price Target: CHF 49.30
Current: $77.55
Upside: -36.43%
Aug 15, 2025
Maintained: Buy
Price Target: 260p → 298p
Current: $219.00
Upside: +36.07%
Aug 11, 2025
Upgraded: Buy
Price Target: €49.00 → €61.50
Current: $51.35
Upside: +19.77%
Feb 25, 2025
Maintained: Buy
Price Target: $16 → $13
Current: $39.80
Upside: n/a
Aug 8, 2024
Maintained: Sell
Price Target: $17 → $18
Current: $23.53
Upside: n/a
May 14, 2024
Maintained: Buy
Price Target: $9.3 → $11
Current: $12.10
Upside: n/a
Jan 5, 2024
Maintained: Hold
Price Target: €4.49
Current: $4.22
Upside: n/a
Nov 8, 2023
Maintained: Hold
Price Target: €49.00
Current: $34.97
Upside: n/a
Feb 23, 2023
Maintained: Buy
Price Target: CHF 147.00 → CHF 148.00
Current: $107.65
Upside: n/a
Nov 22, 2022
Initiated Coverage: Buy
Price Target: 300p
Current: $223.20
Upside: n/a
Feb 8, 2022
Initiated Coverage: Buy
Price Target: kr 630.00 → kr 1,150
Current: $395.74
Upside: n/a
Jan 28, 2022
Downgraded: Hold
Price Target: €135.00 → €43.00
Current: $14.80
Upside: n/a
Aug 27, 2021
Maintained: Sell
Price Target: €28.70
Current: $71.55
Upside: n/a
Jan 20, 2020
Downgraded: Sell
Price Target: n/a
Current: $17.64
Upside: n/a
Dec 5, 2019
Downgraded: Hold
Price Target: n/a
Current: $9.41
Upside: n/a
Nov 1, 2018
Maintained: Buy
Price Target: kr 93.00
Current: $237.50
Upside: n/a
Nov 1, 2017
Maintained: Sell
Price Target: $31
Current: $14.38
Upside: n/a
Aug 21, 2017
Upgraded: Hold
Price Target: n/a
Current: $41.21
Upside: n/a